Goldman Sachs Group Inc Direxion Daily S&P Biotech Bea Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Goldman Sachs Group Inc holds 41,032 shares of LABD stock, worth $278,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,032
Previous 37,933
8.17%
Holding current value
$278,607
Previous $278,000
14.03%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LABD
# of Institutions
25Shares Held
5.14MCall Options Held
1.33MPut Options Held
255K-
Hrt Financial LP New York, NY2.63MShares$17.9 Million0.08% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il950KShares$6.45 Million0.0% of portfolio
-
Virtu Financial LLC New York, NY557KShares$3.78 Million0.18% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA355KShares$2.41 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.53 Million2.28% of portfolio